CN100411650C - A compound capsule for treating Bi syndrome - Google Patents

A compound capsule for treating Bi syndrome Download PDF

Info

Publication number
CN100411650C
CN100411650C CNB2006100440755A CN200610044075A CN100411650C CN 100411650 C CN100411650 C CN 100411650C CN B2006100440755 A CNB2006100440755 A CN B2006100440755A CN 200610044075 A CN200610044075 A CN 200610044075A CN 100411650 C CN100411650 C CN 100411650C
Authority
CN
China
Prior art keywords
grams
gram
compound capsule
radix
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100440755A
Other languages
Chinese (zh)
Other versions
CN1879721A (en
Inventor
张维河
杨百志
周兴仁
杨发祥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100440755A priority Critical patent/CN100411650C/en
Publication of CN1879721A publication Critical patent/CN1879721A/en
Application granted granted Critical
Publication of CN100411650C publication Critical patent/CN100411650C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to a compound capsule for treating rheumatism, which comprises raw materials prepared into the compound capsule: 100 to 180 grams of curare, 40 to 60 grams of centipede, 10 to 30 grams of prepared common monkshood mother root, 10 to 30 grams of prepared kusnezoff monkshood root, 10 to 30 grams of common floweringqince fruit, 12 to 36 grams of angelica, 10 to 30 grams of twotoothed achyranthes root, 10 to 30 grams of radix dipsaci from Sichuan of China, 2 to 3 grams of diclofenac sodium and 0.8 to 1.2 grams of piroxicam. The compound capsule has the advantages of traditional Chinese medicines and western medicines and the effect on expelling cold and dampness, activating channels and relieving pain, and is used for treating various kinds of rheumatism, such as rheumatic rheumatoid arthritis, rheumatic myalgia, periarthritis humeroscapularis, lumbar disc protrusion, hyperosteogeny, sciatica, etc. The compound capsule has the advantages of good treatment effect, obvious effect, low recurrence rate, and safe and convenient utilization.

Description

A kind of compound capsule for the treatment of arthromyodynia
Technical field
The present invention relates to a kind of pharmaceutical composition for the treatment of arthromyodynia, specifically relate to a kind of with in, Western medicine is in conjunction with the medicament capsule of treatment arthromyodynia of preparation.
Background technology
Arthromyodynia is the Chinese medicine noun, and it mainly comprises the multiple muscle of modern medicine indication rheumatic, rheumatoid arthritis and the antalgesic in joint.These diseases belong to commonly encountered diseases, frequently-occurring disease (have data be presented at China can account for the outpatient 10%), delay is difficult, meets inducement and is easy to recurrence, has a strong impact on people's work and life.Though along with medical science applied continuous development, have many relevant new drugs to come out, doctor trained in Western medicine does not have specific medicament so far yet, and rheumatism pain relieving class drug side effect is more, especially easily causes symptom of digestive tract yet, the part drug price is expensive partially, and patient can't bear the heavy load.The traditional Chinese medical science is in expelling wind and cold, eliminating dampness and dredging channels, and in addition blood-activating and qi-promoting is transferred the human righteousness, often can obtain better therapeutic effect, but mostly exist the course of treatment long, slow defective takes effect.
Summary of the invention
Purpose of the present invention is exactly at above-mentioned the deficiencies in the prior art, and a kind of compound medicine capsule is provided, can more effective, more promptly treat the various diseases that belong to rheumatic Bi syndrome such as rheumatic, rheumatoid arthritis.
For achieving the above object, medicine of the present invention is made by following materials of weight proportions medicine: Semen Strychni 100-180 gram, Scolopendra 40-60 gram, Radix Aconiti Preparata 10-30 gram, Radix Aconiti Kusnezoffii Preparata 10-30 gram, Fructus Chaenomelis 10-30 gram, Radix Angelicae Sinensis 12-36 gram, Radix Achyranthis Bidentatae 10-30 gram, Radix Dipsaci 10-30 gram, diclofenac 2-3 gram, piroxicam 0.8-1.2 gram.
The preferred prescription of medicine of the present invention is to be made by following materials of weight proportions medicine: Semen Strychni 150 grams, Scolopendra 50 grams, Radix Aconiti Preparata 20 grams, Radix Aconiti Kusnezoffii Preparata 20 grams, Fructus Chaenomelis 20 grams, Radix Angelicae Sinensis 23 grams, Radix Achyranthis Bidentatae 20 grams, Radix Dipsaci 20 grams, diclofenac 2.5 grams, piroxicam 1 gram.
The preparation method of compound capsule that the present invention treats arthromyodynia is as follows:
1, Semen Strychni is put in the iron pan, it is an amount of to add water, and slow fire boils, and takes out after 8 hours, peels off crust, be cut into thick 0.5-1mm thin slice, airing is fried to being uniform sepia, pulverization, cross the 100-200 mesh sieve, then medicamental pulverata is incapsulated, every capsule powder charge 0.46 gram, this is the I capsule;
2, with in other 9 flavor, western drug mixes, pulverization is crossed the 100-200 mesh sieve, fully incapsulates behind the mix homogeneously, every capsule powder charge 0.5 gram, this is the II capsule.
Consumption and usage: the I capsule is taken once every night, and each 1-3 grain begins to take, gradually dosage in a small amount; The II capsule is taken once every night, each 4, takes simultaneously with the I capsule.
The present invention treats the compound capsule of arthromyodynia with the mutual compatibility of Chinese and western drugs, each most its length, play the effect of expelling cold and dampness, removing obstruction in the collateral to relieve pain altogether, be used for the treatment of various arthromyodynias such as rheumatic rheumatoid arthritis, rheumatic myalgia, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc, hyperosteogeny, sciatica, prove this medicine good effect through clinical trial for many years, instant effect, relapse rate is low, and drug safety is convenient, and medical expense is low.
Clinical observation on the therapeutic effect:
Select patient with rheumatoid arthritis 60 examples, be divided into two groups of treatment group and matched groups at random, every group 30 example.The treatment group is used so that compound capsule of the present invention is conventional: the II capsule is taken 4 every night, and from 1 beginning clothes every night, take the circumstances into consideration increases the I capsule earlier, keeps application after waiting to reach maintenance dose.Matched group is taken Tripterygium glycosides, and 60mg divided and took for 3 times every day, and Qin Pu gives birth to 0.8-1.0g, divides and takes for 2 times.All in 1 month post-evaluation curative effect of treatment.Two groups of cases are all learned by statistics aspect age, sex, the state of an illness and are handled P>0.05, no significant difference.Selected case is the case of the stable disease of making a definite diagnosis by clinical diagnosis of rheumatoid arthritis standard, and does not all use hormone medicine.
Criterion of therapeutical effect: produce effects: symptom and sign is obviously alleviated, and swollen joint obviously disappears, and pain is controlled substantially; Effectively: symptom and sign is partly alleviated, and swollen joint disappears to some extent, and pain alleviates to some extent; Invalid: symptom and sign improves with the preceding nothing of treatment.Therapeutic effect such as following table:
Table 1 treatment group and matched group curative effect are relatively
Figure C20061004407500051
Two groups contrast as can be seen, treatment group obvious effective rate 87%, and matched group obvious effective rate 73%, thereby compound capsule of the present invention has positive effect for the treatment rheumatoid arthritis.
The specific embodiment
Embodiment one
Compound capsule of the present invention is made by following materials of weight proportions medicine: Semen Strychni 100 grams, Scolopendra 60 grams, Radix Aconiti Preparata 10 grams, Radix Aconiti Kusnezoffii Preparata 30 grams, Fructus Chaenomelis 10 grams, Radix Angelicae Sinensis 36 grams, Radix Achyranthis Bidentatae 10 grams, Radix Dipsaci 30 grams, diclofenac 2 grams, piroxicam 0.8 gram.
Embodiment two
Compound capsule of the present invention is made by following materials of weight proportions medicine: Semen Strychni 180 grams, Scolopendra 40 grams, Radix Aconiti Preparata 30 grams, Radix Aconiti Kusnezoffii Preparata 10 grams, Fructus Chaenomelis 30 grams, Radix Angelicae Sinensis 12 grams, Radix Achyranthis Bidentatae 30 grams, Radix Dipsaci 10 grams, diclofenac 3 grams, piroxicam 1.2 grams.
Embodiment three
Compound capsule of the present invention is made by following materials of weight proportions medicine: Semen Strychni 150 grams, Scolopendra 50 grams, Radix Aconiti Preparata 20 grams, Radix Aconiti Kusnezoffii Preparata 20 grams, Fructus Chaenomelis 20 grams, Radix Angelicae Sinensis 23 grams, Radix Achyranthis Bidentatae 20 grams, Radix Dipsaci 20 grams, diclofenac 2.5 grams, piroxicam 1 gram.
Embodiment three is a most preferred embodiment.The preparation method of each embodiment as previously described.

Claims (2)

1. compound capsule for the treatment of arthromyodynia, it is characterized in that making: Semen Strychni 100-180 gram by following materials of weight proportions medicine, Scolopendra 40-60 gram, Radix Aconiti Preparata 10-30 gram, Radix Aconiti Kusnezoffii Preparata 10-30 gram, Fructus Chaenomelis 10-30 gram, Radix Angelicae Sinensis 12-36 gram, Radix Achyranthis Bidentatae 10-30 gram, Radix Dipsaci 10-30 gram, diclofenac 2-3 gram, piroxicam 0.8-1.2 gram.
2. the compound capsule of treatment arthromyodynia according to claim 1, it is characterized in that making: Semen Strychni 150 grams by following materials of weight proportions medicine, Scolopendra 50 grams, Radix Aconiti Preparata 20 grams, Radix Aconiti Kusnezoffii Preparata 20 grams, Fructus Chaenomelis 20 grams, Radix Angelicae Sinensis 23 grams, Radix Achyranthis Bidentatae 20 grams, Radix Dipsaci 20 grams, diclofenac 2.5 grams, piroxicam 1 gram.
CNB2006100440755A 2006-05-09 2006-05-09 A compound capsule for treating Bi syndrome Expired - Fee Related CN100411650C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100440755A CN100411650C (en) 2006-05-09 2006-05-09 A compound capsule for treating Bi syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100440755A CN100411650C (en) 2006-05-09 2006-05-09 A compound capsule for treating Bi syndrome

Publications (2)

Publication Number Publication Date
CN1879721A CN1879721A (en) 2006-12-20
CN100411650C true CN100411650C (en) 2008-08-20

Family

ID=37518222

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100440755A Expired - Fee Related CN100411650C (en) 2006-05-09 2006-05-09 A compound capsule for treating Bi syndrome

Country Status (1)

Country Link
CN (1) CN100411650C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103127300B (en) * 2013-03-08 2014-03-19 崔合芳 Chinese medicinal composition for fumigation treatment of lumbar disc herniation
CN105497441A (en) * 2015-12-30 2016-04-20 杨发祥 Plaster for treating arthralgia

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1247074A (en) * 1998-09-08 2000-03-15 田雪云 Medical capsules for treating arthritides and its preparing process
CN1446567A (en) * 2003-04-04 2003-10-08 康随利 Pill for relaxing muscles and activating collateral flow

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1247074A (en) * 1998-09-08 2000-03-15 田雪云 Medical capsules for treating arthritides and its preparing process
CN1446567A (en) * 2003-04-04 2003-10-08 康随利 Pill for relaxing muscles and activating collateral flow

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
类风湿关节炎中西医结合治疗进展. 马进等.云南中医中药杂志,第25卷第1期. 2004
类风湿关节炎中西医结合治疗进展. 马进等.云南中医中药杂志,第25卷第1期. 2004 *

Also Published As

Publication number Publication date
CN1879721A (en) 2006-12-20

Similar Documents

Publication Publication Date Title
CN101708317B (en) Chinese medicinal composition for treating thyroid disease
CN103341096B (en) Medicine for treating hyperplasia of mammary glands and preparation method thereof
CN100411650C (en) A compound capsule for treating Bi syndrome
CN103948782A (en) Pharmaceutical composition for treating hyperplasia of mammary glands due to stagnation of liver qi as well as preparation method and application of pharmaceutical composition
CN104758451A (en) Traditional Chinese medicine composite for treating gout
CN103877384B (en) A kind of Chinese medicine preparation and preparation method who treats the carcinoma of the rectum
CN102824414A (en) Medicinal tea used for treating constipation
CN102846750B (en) Fengtongning composite preparation and preparation method thereof
CN104096170B (en) External-use ultra-fine powder traditional Chinese medicine for weight loss and preparation method thereof
CN100509003C (en) Medicament of treating psoriasis
CN113244363B (en) Traditional Chinese medicine cake moxibustion for orthopedics department as well as preparation method and application thereof
CN110946905B (en) Traditional Chinese medicine composition applied to acupuncture points of peritoneal dialysis patients and preparation method and application thereof
CN103191170B (en) Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof
CN101194994B (en) Externally used medicament for treating toothache
CN106266152A (en) A kind of pharmaceutical composition treating eczema and its production and use
CN100560087C (en) Pharmaceutical composition of treatment malignant tumor and preparation method thereof
CN1943651B (en) A medicinal composition for treating gout
CN106511579A (en) Medicine composition for treating gynecological diseases and the like
CN1951480A (en) Medicament for treating type 2 diabetes
CN106902295B (en) Toxicity-reducing and efficacy-enhancing traditional Chinese medicine tablet for treating gout with syndrome of wind-damp-heat
CN1709298A (en) Chinese medicine formulation for treating chronic prostatitis and its preparing method
CN101732408B (en) Chinese medicament for treating angitis and limb angiopathy and preparation method thereof
CN103989769B (en) A kind of pharmaceutical composition for health slimming
CN104689246B (en) A kind of medicine for the treatment of gastric cancer
CN1167439C (en) Anticancer Chinese herbal medicine and its prepn

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080820